Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (54)

2023

  1. Association of gamma glutamyl transferase in the presence and progression of abdominal aortic calcifications and changes to bone mineral density

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 15, Núm. 3, pp. 93-99

  2. Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages

    Rheumatology (Oxford, England), Vol. 62, Núm. 8, pp. 2898-2907

  3. Transcriptomic clustering of critically ill COVID-19 patients

    The European respiratory journal, Vol. 61, Núm. 1

2022

  1. Low-density granulocytes: A new marker of bone deterioration in patients on peritoneal dialysis

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 4, pp. 107-114

2021

  1. Association of biochemical parameters of bone metabolism with progression and/or development of new aortic calcifications

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 13, Núm. 1, pp. 10-16

  2. Chronic Kidney Disease—Mineral and Bone Disorders: Pathogenesis and Management

    Calcified Tissue International, Vol. 108, Núm. 4, pp. 410-422

  3. Endocan and circulating progenitor cells in women with systemic sclerosis: Association with inflammation and pulmonary hypertension

    Biomedicines, Vol. 9, Núm. 5

  4. HLA–B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti–Carbamylated Protein Antibody–Positive/Anti–Cyclic Citrullinated Peptide–Negative Rheumatoid Arthritis

    Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 963-969

  5. Novel Immune Cell Subsets Exhibit Different Associations With Vascular Outcomes in Chronic Kidney Disease Patients—Identifying Potential Biomarkers

    Frontiers in Medicine, Vol. 8

  6. Profiling of Serum Oxylipins During the Earliest Stages of Rheumatoid Arthritis

    Arthritis and Rheumatology, Vol. 73, Núm. 3, pp. 401-413

2020

  1. Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two–Lipid Center Real-World Experience

    Journal of Clinical Lipidology, Vol. 14, Núm. 2, pp. 231-240

  2. Biglycan and atherosclerosis: Lessons from high cardiovascular risk conditions

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1865, Núm. 2

  3. Erratum: Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus (Rheumatology (2020) 59 (1752-1764) DOI: 10.1093/rheumatology/keaa016)

    Rheumatology (United Kingdom)

  4. Glyca levels during the earliest stages of rheumatoid arthritis: Potential use as a biomarker of subclinical cardiovascular disease

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-19

  5. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile

    Rheumatology (Oxford, England), Vol. 59, Núm. 2, pp. 407-417

  6. Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus

    Rheumatology (Oxford, England), Vol. 59, Núm. 7, pp. 1752-1764

  7. Mentoring for postdoctoral researchers in rheumatology: The Emerging EULAR Network (EMEUNET) post-doc mentoring programme

    RMD Open, Vol. 6, Núm. 1

  8. Relationship Between T-Cell Exosomes and Cellular Subsets in SLE According to Type I IFN-Signaling

    Frontiers in Medicine, Vol. 7

  9. Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients.

    Progress in Cardiovascular Diseases, Vol. 63, Núm. 3, pp. 327-340

  10. The HDL dysfunction gains momentum: is it time for a new approach in rheumatic diseases?

    Rheumatology (Oxford, England), Vol. 59, Núm. 11, pp. 3121-3123